A Dutch court has declared Bedrocan Nederland B.V. and Bedrocan International B.V. bankrupt, impacting medical cannabis access and reshaping business models in the EU. DMV entrepreneurs must watch for regulatory shifts and new delivery opportunities.

NCV’s data shows flat-to-declining revenue momentum for many public operators while the market fixates on 280E and rescheduling risk—here’s what that means for DMV investors and delivery entrepreneurs.

A new DEA registration pathway pulls state-licensed medical cannabis manufacturers, distributors, and labs into the federal Schedule III framework—potentially easing 280E tax pain.

The Nasdaq notice lifts delisting risk for IM Cannabis and spotlights how bid-price compliance can ripple across marijuana delivery stocks, founders, and DMV investors.

An Oklahoma extraction facility owner faces murder charges following a fatal blast, spotlighting safety and supply chain risk.